Lilly wins FDA approval for treatment for hair loss caused by autoimmunity

Alopecia areata (AA) is an autoimmune condition characterized by non-scarring hair loss on the scalp, face, and body, affecting approximately 2% of the global population. Current treatments, including topical corticosteroids,…

Продолжить чтениеLilly wins FDA approval for treatment for hair loss caused by autoimmunity